Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 7Phase 1 6Phase 1/2 3Phase EARLY_PHASE1 2Phase 4 2Phase 3 2Phase 2/3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Neuroendocrine Tumors 32Multiple Endocrine Neoplasia Type 1 9Neoplasms 8Pituitary Neoplasms 7Carcinoid Tumor 7Pituitary ACTH Hypersecretion 6Gastro-enteropancreatic neuroendocrine tumor 6Differentiated Thyroid Cancer 6Adrenocortical Carcinoma 6Thyroid Cancer, Papillary 5Pituitary Diseases 5Pheochromocytoma 5Thyroid Neoplasms 4Serotonin Syndrome 4Neuroblastoma 4Cushing Syndrome 4Breast Neoplasms 4Acromegaly 4ACTH Syndrome, Ectopic 4Sarcoma 3Liposarcoma 3Insulinoma 3Fibrosarcoma 3Endometrial Neoplasms 3Carcinoma, Medullary 3Adenoma, Islet Cell 3Adenocarcinoma, Follicular 3Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Parkinson Disease 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Adrenal Gland Neoplasms × Endocrine × Clear all
NCT02010957 2025-06-10

FAMIAN

Wuerzburg University Hospital

Phase 3 Terminated
85 enrolled
Endocrine

Adrenal Gland Neoplasms

NCT00037843 2012-02-22

Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening

M.D. Anderson Cancer Center

Phase 3 Completed
114 enrolled
Endocrine

Adrenal Gland Diseases, Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡